Atossa Genetics to Present at the 4th Annual Precision: Breast Cancer World R&D Summit April 25, 2019
SEATTLE, April 22, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, today announced that Steven C. …